Characteristics | Value | Percent |
---|---|---|
Age (y) | ||
- Median | 63.5 | |
- Range | 51–72 | |
Gender | ||
-Female | 5 | 62.5 |
-Male | 3 | 37.5 |
Clinical stage before treatment (n) | ||
-cT2 N1 | 1 | 12.5 |
-cT3 N0–2 | 7 | 87.5 |
Pathological stage (n) | ||
-ypT0 N0 (pCR) | 4 | 50.0 |
-ypT2 N0–1 | 2 | 25.0 |
-ypT3 N0–2 | 2 | 25.0 |
Dworak tumor regression grade (TRG) | ||
-Dominant tumor mass with obvious fibrosis (TRG 1 = minimal regression) | 2 | 25.0 |
-Dominantly fibrotic changes with few tumor cells or groups (TRG 2 = moderate regression) | 1 | 12.5 |
-Very few tumor cells (TRG 3 = near pCR) | 1 | 12.5 |
-No tumor cells (TRG 4 = pCR) | 4 | 50.0 |
Initial tumor volume (ml) | ||
-Median | 33.5 | |
-Range | 14–95 | |
Total treatment time (d) | ||
-Median | 40 | |
-Range | 37–43 |